1 / 48

Liver Toxicity

Liver Toxicity. Andrew Dawson. Outline. Adverse Drug Reactions Definition & Types Examples Mechanisms Revisit some hepatic metabolism Paracetamol Hepatotoxicity Other examples. Toxicity Overview. Drug. Cellular Accumulation. Toxicity. Nucleic Acid Enzyme Transport Protein

masako
Download Presentation

Liver Toxicity

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Liver Toxicity Andrew Dawson

  2. Outline • Adverse Drug Reactions • Definition & Types • Examples • Mechanisms • Revisit some hepatic metabolism • Paracetamol Hepatotoxicity • Other examples

  3. Toxicity Overview Drug Cellular Accumulation Toxicity • Nucleic Acid • Enzyme • Transport Protein • Signalling Protein • Receptor • Autologous protein Carcinogenicity Phase I/II Bioactivation Necrosis Stabile Metabolites Toxic Metabolites Apotosis Bioinactivation Hypersensitivity Excretion

  4. Which ADRs are idiosyncratic, are dose-related? (or other?) A - Augmented (dose-related) B - Bizarre (idiosyncratic) C(?) - Statistical (no identifiable victim) D(?) – Delayed Sheep and goats and ….

  5. Acute ADRs including drug toxicity are commonly categorised into two groups A - Augmented (dose-related) B - Bizarre (idiosyncratic) Adverse Drug Reactions

  6. Type A & Type B ADRs

  7. Allergy Individual variation in pharmacokinetics enzyme polymorphism (perhexilene) renal or hepatic failure (sotalol, chlormethiazole) age (flucloxacillin) Individual variation in pharmacodynamics receptor polymorphism (TCAs) organ failure (hypothyroidism & digoxin) Drug interactions Type B reaction mechanisms

  8. Paracetamol Poisoning: Andrew Dawson

  9. Paracetamol overdose Would you like liver with that? • 24 yo woman takes 24 grams of paracetamol

  10. Objectives • Mechanism • Risk assessment • Treatment

  11. Objectives • Risk assessment • Mechanism • Simple • Advanced • Hepatic drug metabolism • Treatment • Pitfalls • Decontamination • ADR

  12. Paracetamol questions • By what mechanism does paracetamol cause problems in overdose? • Why does the body produce “toxic metabolites” • How can you estimate her risk of hepatic damage? • What is the relevance of alcohol ingestion to the risk of hepatotoxicity?

  13. Normally 85-90% metabolism by conjugation Minor oxidative pathways (P450 enzymes) produces the intermediate toxic metabolite glutathione required for further metabolism to non-toxic metabolites N-acetyl-p-benzoquinonimine

  14. 85% Conjugation P450 Glutathione NAPQI Paracetamol Mechanism N-acetyl-p-benzoquinonamine

  15. CONJUGATION Sulphation & Gluronidation PARACETAMOL P450 TOXIC INTERMEDIATEMETABOLITE SH NON TOXIC METABOLITES MECHANISM OF TOXICITY • When glutathione depleted - the toxic metabolite binds to sulphydryl- containing proteins in the liver cell • Causing cell death (toxic hepatitis)

  16. 90% Conjugation P450 Glutathione NAPQI NAPQI Paracetamol Toxicity

  17. Glutamine synthase Cytosol ADP-ribose pyrophosphatase-1 Glutamylcysteinylsynthetase GAPDH Glutathione S-transferase Methionineadenosyltransferase MIF tautomerase N-10-formyl-H4folate dehydrogenase Protein phosphatase Proteasome Tryptophan-2,3-dioxygenase Aldehyde dehydrogenase Carbamyl phosphate synthase-1 Glutamate dehydrogenase Mg2+ ATPase Ca2+/Mg2+-ATPase Na+/K+-ATPase Enzymes inhibited by binding with NAPQI

  18. NAPQI induced an adaptive defense response

  19. Paracetamol questions • By what mechanism does paracetamol cause problems in overdose? • How does the body produce “toxic metabolites” • How can you estimate her risk of hepatic damage? • What is the relevance of alcohol ingestion to the risk of hepatotoxicity?

  20. How the liver produces toxic metabolites • Phase I • Chemical modification - Oxidation, hydroxylation, etc… • pharmacological inactivation or activation, • facilitatedelimination • addition of reactive groups for subsequentphase II conjugation • Phase II • Conjugation – Inactive, water soluble

  21. Paracetamol questions • By what mechanism does paracetamol cause problems in overdose? • Why does the body produce “toxic metabolites” • How can you estimate her risk of hepatic damage? • What is the relevance of alcohol ingestion to the risk of hepatotoxicity?

  22. 85% Conjugation P450 Glutathione NAPQI takes 24 grams of paracetamol+ alcohol N-acetyl-p-benzoquinonamine

  23. Paracetamol questions • By what mechanism does paracetamol cause problems in overdose? • Why does the body produce “toxic metabolites” • How can you estimate her risk of hepatic damage? • What is the relevance of alcohol ingestion to the risk of hepatotoxicity?

  24. Increase Conjugation Children, the pill Glutathione depletion: chronic ingestion paracetamol, malnutrition Induced P450: chronic alcohol, antiepileptics, barbiturates NAPQI Factors alter risk Blocked P450:acute alcohol, cimetidine

  25. Paracetamol Risk? • 24 yo woman takes 24 grams of paracetamol • Complains of nausea and vomiting, loose bowel motion and abdominal pain. • Paracetamol level • 16 hours = 334 nmol/mL

  26. Risk Assessment for Treatment • Ideally a paracetamol blood level nomogram. • Those on or above the treatment line will require treatment. • Single ingestion • Known time • Best or worst case scenario

  27. Risk by dose • Single • > 200mgs/kg or > 10 grams • Staggered • > 200 mgs/kg or > 10 grams in 24 hours • > 150 mgs/kg or > 6 grams in each 24 hours (48 hours) • > 100 mgs/kg or > 4 grams per day chronic at risk

  28. CONJUGATION Sulphation & Gluronidation PARACETAMOL P450 TOXIC INTERMEDIATEMETABOLITE SH NON TOXIC METABOLITES Factors that may alter risk • Increased conjugation • children, oral contraceptive • Induced P450 • chronic alcohol, antiepileptics, barbiturates • Blocked P450:acute alcohol, cimetidine • Glutathione depletion: chronic ingestion paracetamol, malnutrition

  29. Paracetamol: Treatment • N–acetylcysteine • Glutathione precursor • Antioxidant • Protection from toxicity • Before 8 hours complete protection • 8–24 hours incomplete protection but lower mortality • After 24 hours - shown to decrease mortality in established hepatotoxicity.

  30. Paracetamol: 3 Cases • A 16-year-old female (50 Kg): 1 hour following the ingestion of 10 grams of paracetamol. • A 16-year-old female (50 Kg): 15 hours following the ingestion 12 grams of paracetamol. • A 16-year-old female (120 Kg): 1 hour following the ingestion of 10 grams of paracetamol.

  31. Decontamination:Risk /Benefit • Dose • Time • Method • Nothing • Emesis • Charcoal • Lavage • Whole Bowel Irrigation

  32. Normally 90% metabolism by conjugation Minor oxidative pathways (P450 enzymes) produces the intermediate toxic metabolite glutathione required for further metabolism to non-toxic metabolites N-acetyl-p-benzoquinonimine

  33. Time to N-acetylcysteine (hours) and hepatotoxicity (%) Smilkstein MJ et al. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose: Analysis of the national multicenter study (1976 to 1985). N Engl J Med 1988; 319:1557-1562

  34. NAC • Aim to start Rx within 8 hours • Early toxicity • Glutathionine precursor • SH donor • Late toxicity • ?Free radical scavenging • ?Haemodynamic • ?Other

  35. N-acetylcysteine • 150mg/kg over 15 minutes • 200 ml 5% dextrose i.v. infusion • 50mg/kg over 4 hours • 500ml of 5% dextrose • 100mg/kg over 16 hours • 1L of 5% dextrose

  36. Acute auto-immune hepatitis • A 40 year old woman • Has a drainage of a surgical wound abscess under general anaesthesia • A few days later she has jaundice and severely deranged liver function tests.

  37. Halothane hepatitis Halothane is metabolized by cytochrome P450 2E1 to a chemically reactive trifluoroacetyl radical, which has been shown to covalently modify lysine residues in a range of target proteins Chemical modification of protein(s) leads to the immune response associated with halothane hepatitis.

  38. Ecstasy – Toxic metabolites + Oxidative stress from hyperthermia

  39. Drug Cellular Accumulation Toxicity • Nucleic Acid • Enzyme • Transport Protein • Signalling Protein • Receptor • Autologous protein Carcinogenicity Phase I/II Bioactivation Necrosis Stabile Metabolites Toxic Metabolites Apotosis Bioinactivation Hypersensitvity Excretion

  40. Spectrum of manifestations of drug induced hepatotoxicity • Acute hepatitis – paracetamol, isoniazid, troglitazone • Chronic hepatitis – diclofenac, methyldopa • Acute cholestasis – erythromycin, flucloxacillin • Mixed hepatitis/cholestasis – phenytoin • Chronic cholestasis – chlorpromazine • Fibrosis - methotrexate • Microvesicular steatosis – valproate • Veno-occlusive disease - Cyclophosphamide

  41. Examples of risk factors for drug induced hepatotoxicity • Methotrexate – alcohol, obesity, diabetes, psoriasis • Isoniazid – viral hepatitis, alcohol, acetylator phenotype, rifampicin • Paracetamol – alcohol, fasting • Valproate – other anticonvulsants, genetic metabolic defects • Diclofenac – female, osteoarthritis

  42. Summary of effects of alcohol

More Related